Demographic, socio-environmental, and substance-related predictors of duration of untreated psychosis (DUP)

Schizophrenia Research

Volumn 148, Issue 1-3, 2013, Pages 93-98

  Broussard, Beth ^a   Kelley, Mary E ^b   Wan, Claire Ramsay ^c   Cristofaro, Sarah L ^c   Crisafio, Anthony ^a   Haggard, Patrick J ^c   Myers, Neely L ^a   Reed, Thomas ^a   Compton, Michael T ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Childhood maltreatment; Duration of untreated psychosis; First episode psychosis; Psychosis; Schizophrenia; Treatment delay

Indexed keywords

ADULT; AFRICAN AMERICAN; ALCOHOL CONSUMPTION; ARTICLE; BRIEF PSYCHOTIC DISORDER; CANNABIS ADDICTION; CHILD ABUSE; CRIMINAL JUSTICE; DELUSIONAL DISORDER; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; EARLY DIAGNOSIS; EARLY INTERVENTION; FEMALE; HOSPITALIZATION; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; NEIGHBORHOOD; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; PROGNOSIS; PSYCHIATRIC DEPARTMENT; PSYCHOSIS; PSYCHOSOCIAL ENVIRONMENT; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIFORM DISORDER; SOCIAL STATUS; SUBSTANCE ABUSE; THERAPY DELAY;

CHILDHOOD MALTREATMENT; DURATION OF UNTREATED PSYCHOSIS; FIRST-EPISODE PSYCHOSIS; PSYCHOSIS; SCHIZOPHRENIA; TREATMENT DELAY;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGE OF ONSET; CHILD; CHILD ABUSE; DEMOGRAPHY; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; POVERTY; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; QUESTIONNAIRES; STATISTICS AS TOPIC; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84881027819     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.05.011     Document Type: Article

References (39)

1. Anda R.F., Felitti V.J., Bremner J.D., Walker J.D., Whitfield C., Perry B.D., Dube S.R., Giles W.H. The enduring effects of abuse and related adverse experiences in childhood: a convergence of evidence from neurobiology and epidemiology. Eur. Arch. Psychiatry Clin. Neurosci. 2006, 256:174-186.
2. Barnes T.R., Leeson V.C., Mutsatsa S.H., Watt H.C., Hutton S.B., Joyce E.M. Duration of untreated psychosis and social function: 1year follow-up study of first-episode schizophrenia. Br. J. Psychiatry 2008, 193:203-209.
3. Becker H.E., Nieman D.H., Wiltink S., Dingemans P.M., van der Fliert J.R., Velthorst E., de Haan L., van Amelsvoort T.A., Linszen D.H. Neurocognitive functioning before and after the first psychotic episode: does psychosis result in cognitive deterioration?. Psychol. Med. 2010, 40:1599-1606.
4. Bernstein D.P., Fink L., Handelsman L., Foote J., Lovejoy M., Wenzel K., Sapareto E., Ruggiero J. Initial reliability and validity of a new retrospective measure of child abuse and neglect. Am. J. Psychiatry 1994, 151:1132-1136.
5. Bernstein D.P., Stein J.A., Newcomb M.D., Walker E., Pogge D., Ahluvalia T., Stokes J., Handelsman L., Medrano M., Desmond D., Zule W. Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse Negl. 2003, 27:169-190.
6. Birchwood M., Fowler D., Jackson C. Early Intervention in Psychosis: A Guide to Concepts, Evidence and Interventions 2002, John Wiley & Sons, Chichester, West Sussex, England.
7. Boonstra N., Klaassen R., Sytema S., Marshall M., De Haan L., Wunderink L., Wiersma D. Duration of untreated psychosis and negative symptoms - a systematic review and meta-analysis of individual patient data. Schizophr. Res. 2012, 142:12-19.
8. Brill N., Reichenberg A., Weiser M., Rabinowitz J. Validity of the premorbid adjustment scale. Schizophr. Bull. 2008, 34:981-983.
9. Burns J.K. Cannabis use and duration of untreated psychosis: a systematic review and meta-analysis. Curr. Pharm. Des. 2012, 18:5093-5104.
10. Cannon-Spoor H.E., Potkin S.G., Wyatt R.J. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr. Bull. 1982, 8:470-484.
11. Cockrell J.R., Folstein M.F. Mini-Mental State Examination (MMSE). Psychopharmacol. Bull. 1988, 24:689-692.
12. Compton M.T., Broussard B. Conceptualizing the multi-faceted determinants of the duration of untreated psychosis. Curr. Psychiatry Rev. 2011, 7:1-11.
13. Compton M.T., Chien V.H., Leiner A.S., Goulding S.M., Weiss P.S. Mode of onset of psychosis and family involvement in help-seeking as determinants of duration of untreated psychosis. Soc. Psychiatry Psychiatr. Epidemiol. 2008, 43:975-982.
14. Compton M.T., Goulding S.M., Ramsay C.E., Addington J., Corcoran C., Walker E.F. Early detection and intervention for psychosis: perspectives from North America. Clin. Neuropsychiatry 2008, 5:263-272.
15. Compton M.T., Goulding S.M., Gordon T.L., Weiss P.S., Kaslow N.J. Family-level predictors and correlates of the duration of untreated psychosis in African American first-episode patients. Schizophr. Res. 2009, 115:338-345.
16. Compton M.T., Ramsay C.E., Shim R.S., Goulding S.M., Gordon T.L., Weiss P.S., Druss B. Health services determinants of the duration of untreated psychosis among African-American first-episode patients. Psychiatr. Serv. 2009, 60:1489-1494.
17. Compton M.T., Gordon T.L., Goulding S.M., Esterberg M.L., Carter T., Leiner A.S., Weiss P.S., Druss B.G., Walker E.F., Kaslow N.J. Patient-level predictors and clinical correlates of duration of untreated psychosis among hospitalized first-episode patients. J. Clin. Psychiatry 2011, 72:225-232.
18. Cuesta M.J., García de Jalón E., Campos M.S., Ibáñez B., Sánchez-Torres A.M., Peralta V. Duration of untreated negative and positive symptoms of psychosis and cognitive impairment in first episode psychosis. Schizophr. Res. 2012, 141:222-227.
19. Edwards J., McGorry P.D. Implementing Early Intervention in Psychosis: A Guide to Establishing Early Psychosis Services 2002, Martin Dunitz, London.
20. Felitti V.J., Anda R.F., Nordenberg D., Williamson D.F., Spitz A.M., Edwards V., Koss M.P., Marks J.S. Relationships of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am. J. Prev. Med. 1998, 14:245-258.
21. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders (Clinical Version) SCID-I 1997, American Psychiatric Publishing, Arlington, VA.
22. Folstein M.F., Folstein S.E., McHugh P.R. Mini-Mental State: A Practical Method for Grading the Cognitive State of Patients for the Clinician 1975, Pergamon Press, Oxford.
23. Goldberg T.E., Burdick K.E., McCormack J., Napolitano B., Patel R.C., Sevy S.M., Goldman R., Lencz T., Malhotra A.K., Kane J.M., Robinson D.G. Lack of an inverse relationship between duration of untreated psychosis and cognitive function in first episode schizophrenia. Schizophr. Res. 2009, 107:262-266.
24. Jablensky A., Sartorius N., Ernberg G., Anker M., Korten A., Cooper J.E., Day R., Bertelsen A. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol. Med. Monogr. Suppl. 1992, 20:1-97.
25. Kern R.S., Nuechterlein K.H., Green M.F., Baade L.E., Fenton W.S., Gold J.M., Keefe R.S., Mesholam-Gately R., Mintz J., Seidman L.J., Stover E., Marder S.R. The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. Am. J. Psychiatry 2008, 165:214-220.
26. Lappin J.M., Morgan K.D., Morgan C., Dazzan P., Reichenberg A., Zanellia J.W., Fearon P., Jones P.B., Lloyd T., Tarrant J., Farrant A., Leff J., Murray R.M. Duration of untreated psychosis and neuropsychological function in first episode psychosis. Schizophr. Res. 2007, 95:103-110.
27. Malla A.K., Bodnar M., Joober R., Lepage M. Duration of untreated psychosis is associated with orbital-frontal grey matter volume reductions in first episode psychosis. Schizophr. Res. 2011, 125:13-20.
28. Marshall M., Lewis S., Lockwood A., Drake R., Jones P., Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch. Gen. Psychiatry 2005, 62:975-983.
29. Maxwell M.E. Manual for the FIGS. Clinical Neurogenetics Branch, Intramural Research Program 1992, National Institute of Mental Health.
30. McGlashan T.H. Premorbid adjustment, onset types, and prognostic scaling: still informative?. Schizophr. Bull. 2008, 34:801-805.
31. Monte R.C., Goulding S.M., Compton M.T. Premorbid functioning of patients with first-episode nonaffective psychosis: a comparison of deterioration in academic and social performance, and clinical correlates of Premorbid Adjustment Scale scores. Schizophr. Res. 2008, 104:206-213.
32. Nuechterlein K.H., Green M.F., Kern R.S., Baade L.E., Barch D.M., Cohen J.D., Essock S., Fenton W.S., Frese F.J., Gold J.M., Goldberg T., Heaton R.K., Keefe R.S., Kraemer H., Mesholam-Gately R., Seidman L.J., Stover E., Weinberger D.R., Young A.S., Zalcman S., Marder S.R. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am. J. Psychiatry 2008, 165:203-213.
33. Pek E., Mythily S., Chong S.A. Clinical and social determinants of duration of untreated psychosis in first-episode psychosis patients. Ann. Acad. Med. Singapore 2006, 35:24-26.
34. Perkins D.O., Leserman J., Jarskog L.F., Graham K., Kazmer J., Lieberman J.A. Characterizing and dating the onset of symptoms in psychotic illness: the Symptom Onset in Schizophrenia (SOS) inventory. Schizophr. Res. 2000, 44:1-10.
35. Perkins D.O., Gu H., Boteva K., Lieberman J.A. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am. J. Psychiatry 2005, 162:1785-1804.
36. Ramsay C.E., Compton M.T. The interface of cannabis misuse and schizophrenia-spectrum disorders. Handbook of Schizophrenia Spectrum Disorders, Volume III: Therapeutic Approaches, Comorbidity, and Outcomes 2011, 289-320. Springer, New York. M.S. Ritner (Ed.).
37. Ramsay C.E., Abedi G.R., Marson J.D., Compton M.T. Overview and initial validation of two detailed, multidimensional, retrospective measures of substance use: the Lifetime Substance Use Recall (LSUR) and Longitudinal Substance Use Recall for 12 weeks (LSUR-12) instruments. J. Psychiatr. Res. 2011, 45:83-91.
38. Ross C.E., Mirowsky J. Disorder and decay: the concept and measurement of perceived neighborhood disorder. Urban Aff. Rev. 1999, 34:412-432.
39. Rund B.R., Melle I., Friis S., Johannessen J.O., Larsen T.K., Midbøe L.J., Opjordsmoen S., Simosen E., Vaglum P., McGlashan T. The course of neurocognitive functioning in first-episode psychosis and its relation to premorbid adjustment, duration of untreated psychosis, and relapse. Schizophr. Res. 2007, 91:132-140.